Welcome to our dedicated page for WEALTHFRONT SEC filings (Ticker: WLTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on WEALTHFRONT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into WEALTHFRONT's regulatory disclosures and financial reporting.
Wealthfront Corp reported that a director and 10% owner converted multiple series of preferred stock into common shares on 12/15/2025 in connection with the completion of its initial public offering of common stock. According to the terms in its restated certificate of incorporation, each share of the preferred stock series automatically converted into common stock at a 1-for-1 ratio and the preferred securities have no expiration date.
Following these conversions, the Rachleff Family Revocable Trust UTD 5/19/92, for which the reporting person and spouse are co-trustees, beneficially owns 16,424,204 Wealthfront common shares indirectly. Two additional 2015 irrevocable trusts for the reporting person’s children each directly hold 403,225 common shares, with the reporting person and spouse also serving as co-trustees of those trusts.
A director of Wealthfront Corp reported multiple equity award exercises and settlements that increased their direct ownership to 558,981 shares of common stock. On October 15, 2025, the director exercised stock options for 100,000 shares at $1.67 per share and 200,000 shares at $1.16 per share, converting fully vested options into common stock in exempt transactions with the company.
On December 11, 2025, 258,981 restricted stock units were settled into an equal number of common shares at no cash cost, and 117,719 RSUs remained outstanding afterward. The RSU award included a performance condition satisfied in connection with Wealthfront’s initial public offering and continues to vest quarterly, with units either vesting into shares or being cancelled.
Wealthfront Corp director reported several equity transactions around the company’s initial public offering. On December 11, 2025, multiple restricted stock unit awards vested and were settled into 6,945, 27,778, 30,500 and 15,496 shares of Wealthfront common stock at an exercise price of $0 per share. After these settlements, the reporting person held 80,719 common shares directly.
On the same date, the reporting person sold 38,071 common shares and the Goldman-Valeriote Family Trust sold 5,373 common shares at $14 per share as part of the issuer’s secondary offering in conjunction with the IPO, leaving 42,648 shares held directly and none held indirectly for that sale line. Earlier, on July 17, 2025, the trust made a 25,000-share gift of Series C preferred stock for no consideration. In connection with completion of the IPO, 53,732 shares of Series C preferred held by the trust automatically converted into 53,732 common shares on December 15, 2025, resulting in 48,359 common shares held indirectly by the trust, for which the reporting person serves as trustee.
A director of Wealthfront Corp reported exercising stock options and selling shares in conjunction with the company’s initial public offering. On December 11, 2025, the director exercised 10,000 stock options at $2.91 per share, receiving 10,000 shares of common stock. The same day, the director sold 10,000 common shares at $14.00 per share as part of a secondary offering tied to the IPO, leaving no directly owned common shares and 290,000 stock options outstanding.
Wealthfront Corp’s Chief Technology Officer reported significant equity award activity and share sales tied to the company’s IPO. The insider reported a grant of 304,000 restricted stock units on 10/13/2025, each representing a right to receive one share of common stock, with vesting tied to performance conditions satisfied in connection with the IPO and an ongoing service-based schedule.
On 12/11/2025, multiple restricted stock unit awards were settled for common stock at an exercise price of $0. The issuer withheld 373,717 shares of common stock at $14 per share to cover tax obligations, and the CTO sold 120,000 shares at $14 per share as part of the issuer’s secondary offering in conjunction with its initial public offering. Following these transactions, the CTO directly owned 475,308 shares of Wealthfront common stock, with the new 304,000-unit award scheduled to vest quarterly starting on March 15, 2026, subject to continued service.
Wealthfront Corp executive Lauren Lin, the company's CLO, CCO and Secretary, reported multiple equity transactions. On 12/11/2025, several restricted stock unit awards were settled into common stock at an exercise price of $0, increasing her direct holdings before taxes.
On the same date, 129,493 shares of common stock were withheld at $14 per share to satisfy tax withholding obligations, and 30,229 shares were sold at $14 per share as part of the company's secondary offering conducted in conjunction with its IPO. After these transactions, she directly owned 95,279 shares of common stock.
The filing also reports a new grant on 09/26/2025 of 205,550 restricted stock units. These units became performance-eligible in connection with the IPO and are scheduled to vest in 16 equal quarterly installments on the fifteenth day of March, June, September and December, beginning December 15, 2025, subject to her continued service.
Wealthfront Corp's VP of Engineering reported multiple stock and restricted stock unit transactions on December 11, 2025.
Several restricted stock unit awards were converted into Common Stock at $0 per share, increasing direct holdings before shares were withheld and sold. The issuer withheld 304,599 shares at $14 to satisfy tax withholding liabilities and the officer sold 167,722 shares at $14 as part of a secondary offering in conjunction with the IPO, leaving 127,514 shares of Common Stock owned directly.
The underlying restricted stock units were subject to performance-based vesting conditions satisfied in connection with the IPO and service-based vesting schedules, with portions vesting quarterly and some awards already fully vested and settled into shares.
Wealthfront Corp (WLTH) CFO and Treasurer reported multiple equity transactions involving company stock. On 09/05/2025, she exercised a stock option for 40,000 shares of common stock at $2.45 per share in an exempt transaction with the issuer. On 12/11/2025, restricted stock units were settled for 95,785, 159,687, and 70,875 shares of common stock, and the issuer withheld 118,893 shares at $14 per share to cover tax obligations. She also sold 100,000 shares of common stock at $14 per share, participating in the issuer’s secondary offering in conjunction with its IPO, and held 186,865 shares directly afterward.
The filing also shows an award of 284,200 restricted stock units subject to performance-based conditions satisfied in connection with the IPO and a service-based schedule that vests quarterly on March 15, June 15, September 15, and December 15, with certain tranches vesting through March 15, 2026, contingent on continued service. Time-vested portions of some awards were settled for shares in connection with the IPO.
Wealthfront Corp.'s CEO, president and director reported extensive equity activity in the company’s common stock. On December 11, 2025, multiple restricted stock unit awards and stock options were exercised and settled into shares, with many awards’ performance conditions satisfied in connection with the IPO.
The reporting person had 1,528,003 shares withheld at $14 per share to cover tax obligations from RSU settlements, then sold 765,154 shares at $14 as part of the issuer’s secondary offering in conjunction with its initial public offering. Additional option exercises added 220,000, 242,000 and 162,784 shares at exercise prices of $2.45, $1.67 and $1.50, leaving 1,481,051 shares held directly after the transactions and 153,503 shares held indirectly through a spouse, who also exercised and sold shares on the same date.
Wealthfront Corporation is conducting an initial public offering of 34,615,384 shares of common stock at $14.00 per share, consisting of 21,468,038 new shares from the company and 13,147,346 shares from selling stockholders. The company expects to receive approximately $282.1 million in gross proceeds before expenses, while selling stockholders will receive about $172.7 million; the company will not receive any proceeds from their sales. Underwriters have a 30-day option to purchase up to an additional 5,192,308 shares from Wealthfront at the IPO price less underwriting discounts. At the midpoint of its recent preliminary results for the quarter ended October 31, 2025, Wealthfront estimates revenue growth of about the mid-teens percentage year over year, continued strong profitability with net income around $29–30 million, and Adjusted EBITDA rising to roughly the mid-$40 million range, supported by growing platform assets and a largely cash-management-driven revenue mix.